Leonardo G B Ferreira1, Jessika P Prevatto1, Hercules R Freitas2, Ricardo A M Reis2, Patrícia M R Silva1, Marco A Martins1, Robson X Faria3, Vinicius F Carvalho4,5. 1. Laboratório de Inflamação, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Av. Brasil, No. 4365, Manguinhos, 21045-900, Rio de Janeiro, Brazil. 2. Laboratório de Neuroquímica, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho, No. 373; Cidade Universitária, Ilha do Fundão, 21941-902, Rio de Janeiro, Brazil. 3. Laboratório de Toxoplasmose e Outras Protozooses, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Av. Brasil, No. 4365, Manguinhos, 21045-900, Rio de Janeiro, Brazil. 4. Laboratório de Inflamação, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Av. Brasil, No. 4365, Manguinhos, 21045-900, Rio de Janeiro, Brazil. vfrias@ioc.fiocruz.br. 5. Instituto Nacional de Ciência e Tecnologia em Neuroimunomodulação (INCT-NIM), Manguinhos, Brazil. vfrias@ioc.fiocruz.br.
Abstract
INTRODUCTION: Glucocorticoid release by adrenals has been described as significant to survive sepsis. The activation of transient receptor potential vanilloid type 1 (TRPV1) inhibited ACTH-induced glucocorticoid release by adrenal glands in vitro. OBJECTIVE: The aim of this study was to investigate if capsaicin, an activator of TRPV1, would prevent LPS-induced glucocorticoid production by adrenals. METHODS: Male Swiss-Webster mice were treated with capsaicin intraperitoneally (0.2 or 2 mg/kg) 30 min before LPS injection. All analyses were performed 2 h after the LPS stimulation, including plasma corticosterone and peritoneal IL-1β and TNF-α levels. Furthermore, murine adrenocortical Y1 cells were used to assess the effects of capsaicin on LPS-induced corticosterone production in vitro. RESULTS: Capsaicin (2 mg/kg, i.p.) significantly reduced plasma corticosterone levels and adrenal hypertrophy induced by LPS without alter the levels of pro-steroidogenic cytokines IL-1β and TNF-α in peritoneal cavity of mice, while the dose of 0.2 mg/kg of capsaicin did not interfere with adrenal steroidogenesis, attested by RIA and ELISA, respectively. Y1 cells express TRPV1, measured by immunofluorescence and western blot, and capsaicin decreased LPS-induced corticosterone production by these cells in vitro. Capsaicin also induces calcium mobilization in Y1 cells in vitro. CONCLUSIONS: These findings suggest that capsaicin inhibits corticosterone production induced by LPS by acting directly on adrenal cells producing glucocorticoids, in a mechanism probably associated with induction of a cytoplasmic calcium increase in these cells.
INTRODUCTION: Glucocorticoid release by adrenals has been described as significant to survive sepsis. The activation of transient receptor potential vanilloid type 1 (TRPV1) inhibited ACTH-induced glucocorticoid release by adrenal glands in vitro. OBJECTIVE: The aim of this study was to investigate if capsaicin, an activator of TRPV1, would prevent LPS-induced glucocorticoid production by adrenals. METHODS: Male Swiss-Webster mice were treated with capsaicin intraperitoneally (0.2 or 2 mg/kg) 30 min before LPS injection. All analyses were performed 2 h after the LPS stimulation, including plasma corticosterone and peritoneal IL-1β and TNF-α levels. Furthermore, murineadrenocortical Y1 cells were used to assess the effects of capsaicin on LPS-induced corticosterone production in vitro. RESULTS:Capsaicin (2 mg/kg, i.p.) significantly reduced plasma corticosterone levels and adrenal hypertrophy induced by LPS without alter the levels of pro-steroidogenic cytokines IL-1β and TNF-α in peritoneal cavity of mice, while the dose of 0.2 mg/kg of capsaicin did not interfere with adrenal steroidogenesis, attested by RIA and ELISA, respectively. Y1 cells express TRPV1, measured by immunofluorescence and western blot, and capsaicin decreased LPS-induced corticosterone production by these cells in vitro. Capsaicin also induces calcium mobilization in Y1 cells in vitro. CONCLUSIONS: These findings suggest that capsaicin inhibits corticosterone production induced by LPS by acting directly on adrenal cells producing glucocorticoids, in a mechanism probably associated with induction of a cytoplasmic calcium increase in these cells.
Authors: Pablo Nicolás Surkin; Sofia Ludmila Gallino; Valeria Luce; Fernando Correa; Javier Fernandez-Solari; Andrea De Laurentiis Journal: Psychoneuroendocrinology Date: 2017-10-18 Impact factor: 4.905
Authors: Stefan R Bornstein; William C Engeland; Monika Ehrhart-Bornstein; James P Herman Journal: Trends Endocrinol Metab Date: 2008-04-03 Impact factor: 12.015
Authors: Paul J Lucassen; Jens Pruessner; Nuno Sousa; Osborne F X Almeida; Anne Marie Van Dam; Grazyna Rajkowska; Dick F Swaab; Boldizsár Czéh Journal: Acta Neuropathol Date: 2013-12-08 Impact factor: 17.088
Authors: Jessika P Prevatto; Rafael C Torres; Bruno L Diaz; Patrícia M R E Silva; Marco A Martins; Vinicius F Carvalho Journal: Oxid Med Cell Longev Date: 2017-05-09 Impact factor: 6.543
Authors: Hercules R Freitas; Gabriel Ferraz; Gustavo C Ferreira; Victor T Ribeiro-Resende; Luciana B Chiarini; José Luiz M do Nascimento; Karen Renata H Matos Oliveira; Tiago de Lima Pereira; Leonardo G B Ferreira; Regina C Kubrusly; Robson X Faria; Anderson Manoel Herculano; Ricardo A de Melo Reis Journal: PLoS One Date: 2016-04-14 Impact factor: 3.240
Authors: Ana Rosa Pérez; Alexandre Morrot; Vinicius Frias Carvalho; Juliana de Meis; Wilson Savino Journal: Front Endocrinol (Lausanne) Date: 2018-06-14 Impact factor: 5.555